Artigos (12) Publicacións nas que participase algún/ha investigador/a

2017

  1. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

    Nature Genetics, Vol. 49, Núm. 1, pp. 27-35

  2. Discontinuation of Peritoneal Dialysis after Late Initiation of Eculizumab in a Case of Familial Atypical Hemolytic-Uremic Syndrome: A Case Report

    Case Reports in Nephrology and Dialysis, Vol. 7, Núm. 1, pp. 18-25

  3. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

  4. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

    Nature Communications, Vol. 8

  5. How a Bottom-Up Multi-Stakeholder Initiative Helped Transform the Renal Replacement Therapy Landscape in Spain

    Applied Health Economics and Health Policy, Vol. 15, Núm. 6, pp. 755-762

  6. Incidence of cardiovascular events and associated risk factors in kidney transplant patients: A competing risks survival analysis

    BMC Cardiovascular Disorders, Vol. 17, Núm. 1

  7. Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study

    Nephron, Vol. 136, Núm. 2, pp. 111-120

  8. NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology

    Scientific Reports, Vol. 7, Núm. 1

  9. Peritoneal Water Transport Characteristics of Diabetic Patients Undergoing Peritoneal Dialysis: A Longitudinal Study

    American Journal of Nephrology, Vol. 46, Núm. 1, pp. 47-54

  10. Recent progress of the ARegPKD registry study on autosomal recessive polycystic kidney disease

    Frontiers in Pediatrics, Vol. 5

  11. Testosterone deficiency in dialysis patients: Difference between dialysis techniques

    Nefrologia, Vol. 37, Núm. 5, pp. 526-530

  12. The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

    PLoS ONE, Vol. 12, Núm. 11